Skip to main
AHCO

AdaptHealth Corp (AHCO) Stock Forecast & Price Target

AdaptHealth Corp (AHCO) Analyst Ratings

Based on 7 analyst ratings
Strong Buy
Strong Buy 57%
Buy 43%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

AdaptHealth is poised to continue its strong performance in its primary segment, Sleep Health, while also seeing growth and progress in its other segments, particularly in Respiratory and Diabetes. The company's focus on providing patient-centered, healthcare-at-home solutions puts it in a prime position to benefit from the current trend of shifting healthcare services to the home. With strong visibility into labor cost normalization, continued expansion of cross-selling opportunities, and a robust capitated pipeline, we believe AdaptHealth has the potential for significant margin expansion and long-term growth.

Bears say

AdaptHealth is an innovative leader in the DME industry and has first-mover advantages, but potential for disruption to operations and reimbursement pressure from government and third-party payors pose major risks. Despite steady revenue growth in its Sleep Health segment, the company's adjusted EBITDA for 2026 and 2027 may fall below previous estimates, leading to a lowered price target of $12 (from $13). Additionally, potential regulatory issues and economic downturn could impact demand and patient payment ability.

AdaptHealth Corp (AHCO) has been analyzed by 7 analysts, with a consensus rating of Strong Buy. 57% of analysts recommend a Strong Buy, 43% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AdaptHealth Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AdaptHealth Corp (AHCO) Forecast

Analysts have given AdaptHealth Corp (AHCO) a Strong Buy based on their latest research and market trends.

According to 7 analysts, AdaptHealth Corp (AHCO) has a Strong Buy consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AdaptHealth Corp (AHCO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.